The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms

NCT00000990 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)